Basic and clinical aspects of atopic dermatitis

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The history of ectopic dermatitis is replete with many disparate theories. The most enduring is the allergic causation therapy but definitive, convincing evidence remains elusive. Elevated IgE synthesis is well established and reflects abnormal immune regulation. The basic mechanism for the regulatory defect remains conjectural. Cellular immune functions, including delayed cutaneous hypersensitivity, in vitro lymphocyte transformation and chemotaxis are reduced in ectopic dermatitis. However, these abnormalities fluctuate with the clinical condition and may be secondary phenomena. A number of physiologic and pharmacologic abnormalities in ectopic dermatitis are not clearly understood. Recent studies of patients leukocytes have shown that the diminished cyclic AMP responses are a consequence of increased catabolism by elevated cyclic AMP-specific phosphodiesterase. This high enzyme correlates well with elevated IgE synthesis and histamine release by cultured leukocytes. Both of these functions can be reduced by phosphodiesterase inhibitors in vitro. These new investigations provide fresh insight into the pathogenesis of ectopic dermatitis and offer possible new therapeutic approaches. Basic studies of biochemical abnormalities may help define the defective molecular site that accounts for the many immune and physiologic abnormalities that have been described in ectopic dermatitis and the other atopic conditions.

Original languageEnglish (US)
Pages (from-to)386-395
Number of pages10
JournalAnnals of Allergy
Volume52
Issue number6
StatePublished - 1984

Fingerprint

Dermatitis
Atopic Dermatitis
Cyclic AMP
Immunoglobulin E
Leukocytes
Phosphodiesterase Inhibitors
Histamine Release
Phosphoric Diester Hydrolases
Delayed Hypersensitivity
Chemotaxis
Lymphocyte Activation
Causality
History
Skin
Enzymes
Therapeutics
In Vitro Techniques

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Basic and clinical aspects of atopic dermatitis. / Hanifin, Jon.

In: Annals of Allergy, Vol. 52, No. 6, 1984, p. 386-395.

Research output: Contribution to journalArticle

@article{5b92eaef196840248e0c23a8657762a3,
title = "Basic and clinical aspects of atopic dermatitis",
abstract = "The history of ectopic dermatitis is replete with many disparate theories. The most enduring is the allergic causation therapy but definitive, convincing evidence remains elusive. Elevated IgE synthesis is well established and reflects abnormal immune regulation. The basic mechanism for the regulatory defect remains conjectural. Cellular immune functions, including delayed cutaneous hypersensitivity, in vitro lymphocyte transformation and chemotaxis are reduced in ectopic dermatitis. However, these abnormalities fluctuate with the clinical condition and may be secondary phenomena. A number of physiologic and pharmacologic abnormalities in ectopic dermatitis are not clearly understood. Recent studies of patients leukocytes have shown that the diminished cyclic AMP responses are a consequence of increased catabolism by elevated cyclic AMP-specific phosphodiesterase. This high enzyme correlates well with elevated IgE synthesis and histamine release by cultured leukocytes. Both of these functions can be reduced by phosphodiesterase inhibitors in vitro. These new investigations provide fresh insight into the pathogenesis of ectopic dermatitis and offer possible new therapeutic approaches. Basic studies of biochemical abnormalities may help define the defective molecular site that accounts for the many immune and physiologic abnormalities that have been described in ectopic dermatitis and the other atopic conditions.",
author = "Jon Hanifin",
year = "1984",
language = "English (US)",
volume = "52",
pages = "386--395",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "6",

}

TY - JOUR

T1 - Basic and clinical aspects of atopic dermatitis

AU - Hanifin, Jon

PY - 1984

Y1 - 1984

N2 - The history of ectopic dermatitis is replete with many disparate theories. The most enduring is the allergic causation therapy but definitive, convincing evidence remains elusive. Elevated IgE synthesis is well established and reflects abnormal immune regulation. The basic mechanism for the regulatory defect remains conjectural. Cellular immune functions, including delayed cutaneous hypersensitivity, in vitro lymphocyte transformation and chemotaxis are reduced in ectopic dermatitis. However, these abnormalities fluctuate with the clinical condition and may be secondary phenomena. A number of physiologic and pharmacologic abnormalities in ectopic dermatitis are not clearly understood. Recent studies of patients leukocytes have shown that the diminished cyclic AMP responses are a consequence of increased catabolism by elevated cyclic AMP-specific phosphodiesterase. This high enzyme correlates well with elevated IgE synthesis and histamine release by cultured leukocytes. Both of these functions can be reduced by phosphodiesterase inhibitors in vitro. These new investigations provide fresh insight into the pathogenesis of ectopic dermatitis and offer possible new therapeutic approaches. Basic studies of biochemical abnormalities may help define the defective molecular site that accounts for the many immune and physiologic abnormalities that have been described in ectopic dermatitis and the other atopic conditions.

AB - The history of ectopic dermatitis is replete with many disparate theories. The most enduring is the allergic causation therapy but definitive, convincing evidence remains elusive. Elevated IgE synthesis is well established and reflects abnormal immune regulation. The basic mechanism for the regulatory defect remains conjectural. Cellular immune functions, including delayed cutaneous hypersensitivity, in vitro lymphocyte transformation and chemotaxis are reduced in ectopic dermatitis. However, these abnormalities fluctuate with the clinical condition and may be secondary phenomena. A number of physiologic and pharmacologic abnormalities in ectopic dermatitis are not clearly understood. Recent studies of patients leukocytes have shown that the diminished cyclic AMP responses are a consequence of increased catabolism by elevated cyclic AMP-specific phosphodiesterase. This high enzyme correlates well with elevated IgE synthesis and histamine release by cultured leukocytes. Both of these functions can be reduced by phosphodiesterase inhibitors in vitro. These new investigations provide fresh insight into the pathogenesis of ectopic dermatitis and offer possible new therapeutic approaches. Basic studies of biochemical abnormalities may help define the defective molecular site that accounts for the many immune and physiologic abnormalities that have been described in ectopic dermatitis and the other atopic conditions.

UR - http://www.scopus.com/inward/record.url?scp=0021234090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021234090&partnerID=8YFLogxK

M3 - Article

VL - 52

SP - 386

EP - 395

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 6

ER -